JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Résumé
This editorial refers to the article ‘JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis’, published by Gillard L. et al., 2023;62: 1594–1604.
Domaines
![]()
Cite hal-03849961 Article Louise Gillard, Jacques Pouchot, Fleur Cohen-Aubart, Isabelle Koné-Paut, Gaël Mouterde, et al.. JAK Inhibitors in Difficult-to-Treat Adult-Onset Still's Disease and Systemic-Onset Juvenile Idiopathic Arthritis. Rheumatology, 2022, pp.keac440. ⟨10.1093/rheumatology/keac440⟩. ⟨hal-03849961⟩